NUVATION BIO INC

Markel Stacy’s strategic buy‑sell moves reveal Nuvation Bio’s leaders stay invested and confident amid a 227% YTD surge, offering investors insight into insider confidence.

Insider buying shows confidence in Nuvation Bio’s long‑term value – a small purchase by Robert Mashal at $4.73, reinforcing bullish sentiment amid clinical‑milestone anticipation.

Insightful look at Nuvation Bio’s insider trades: Kerry’s strategic buy‑sell‑buy signals confidence amid a rally and upcoming earnings.

Insider option buying at Nuvation signals leadership confidence – a bullish cue amid a steep price decline, hinting at future upside if clinical data deliver.